Display options
Cite
Nalcacioglu-Yuksekkaya P, Sen E, Elgin U, et al. Corneal properties in children with congenital isolated growth hormone deficiency. Int J Ophthalmol. 2014;7(2):317-20doi: 10.3980/j.issn.2222-3959.2014.02.22.
Nalcacioglu-Yuksekkaya, P., Sen, E., Elgin, U., Hocaoglu, M., Ozturk, F., Yilmaz, S. A., Kendirci, H. N., Cetinkaya, S., & Aycan, Z. (2014). Corneal properties in children with congenital isolated growth hormone deficiency. International journal of ophthalmology, 7(2), 317-20. https://doi.org/10.3980/j.issn.2222-3959.2014.02.22
Nalcacioglu-Yuksekkaya, Pinar, et al. "Corneal properties in children with congenital isolated growth hormone deficiency." International journal of ophthalmology vol. 7,2 (2014): 317-20. doi: https://doi.org/10.3980/j.issn.2222-3959.2014.02.22
Nalcacioglu-Yuksekkaya P, Sen E, Elgin U, Hocaoglu M, Ozturk F, Yilmaz SA, Kendirci HN, Cetinkaya S, Aycan Z. Corneal properties in children with congenital isolated growth hormone deficiency. Int J Ophthalmol. 2014 Apr 18;7(2):317-20. doi: 10.3980/j.issn.2222-3959.2014.02.22. eCollection 2014. PMID: 24790877; PMCID: PMC4003089.
Copy Download .nbib Format: NLM
Share it on

Int J Ophthalmol. 2014 Apr 18;7(2):317-20. doi: 10.3980/j.issn.2222-3959.2014.02.22. eCollection 2014.

Corneal properties in children with congenital isolated growth hormone deficiency.

International journal of ophthalmology

Pinar Nalcacioglu-Yuksekkaya, Emine Sen, Ufuk Elgin, Mumin Hocaoglu, Faruk Ozturk, Sebahat Agladıoglu Yilmaz, Havva Nur Kendirci, Semra Cetinkaya, Zehra Aycan

Affiliations

  1. Department of Pediatric Ophthalmology, Dr Sami Ulus Children's Health and Disease Training and Research Hospital, Ankara 06080, Turkey.
  2. Ulucanlar Eye Research Hospital, Ankara 06240, Turkey.
  3. Department of Pediatric Endocrinology, Dr Sami Ulus Children's Health and Disease Training and Research Hospital, Ankara 06080, Turkey.

PMID: 24790877 PMCID: PMC4003089 DOI: 10.3980/j.issn.2222-3959.2014.02.22

Abstract

AIM: To compare the corneal parameters of children with congenital isolated growth hormone deficiency and healthy subjects.

METHODS: In this cross-sectional, prospective study, 50 cases with growth hormone (GH) deficiency treated with recombinant GH and 71 healthy children underwent a complete ophthalmic examination. The corneal hysteresis (CH), corneal resistance factor (CRF), Goldmann-correlated intraocular pressure (IOPg) and corneal-compensated intraocular pressure (IOPcc) were measured with the Ocular Response Analyzer (ORA). Central corneal thickness (CCT) was measured by a ultrasonic pachymeter.

RESULTS: The mean age was 13.0±3.0 years in the GH deficiency group consisting of 21 females and 29 males and 13.4±2.4 years in the healthy children group consisting of 41 females and 30 males. There was no statistically significant difference between the groups for gender or age (Chi-square test, P=0.09; independent t-test, P=0.28, respectively). The mean duration of recombinant GH therapy was 3.8±2.4y in the study group. The mean CH, CRF, IOPg and IOPcc values were 11.0±2.0, 10.9±1.9, 15.1±3.3, and 15.1±3.2 mm Hg respectively in the study group. The same values were 10.7±1.7, 10.5±1.7, 15.2±3.3, and 15.3±3.4 mm Hg respectively in the control group. The mean CCT values were 555.7±40.6, 545.1±32.5 µm in the study and control groups respectively. There was no statistically significant difference between the two groups for CH, CRF, IOPg, IOPcc measurements or CCT values (independent t-test, P=0.315, 0.286, 0.145, 0.747, 0.13 respectively).

CONCLUSION: Our study suggests that GH deficiency does not have an effect on the corneal parameters and CCT values. This observation could be because of the duration between the beginning of disease and the diagnosis and beginning of GH therapy.

Keywords: central corneal thickness; child; corneal biomechanical parameters; growth hormone deficiency

References

  1. J Endocrinol. 2001 Jun;169(3):487-98 - PubMed
  2. J Pediatr. 1994 Jul;125(1):29-35 - PubMed
  3. Curr Opin Ophthalmol. 2008 Mar;19(2):122-6 - PubMed
  4. Acta Ophthalmol. 2010 Sep;88(6):692-4 - PubMed
  5. Exp Eye Res. 2001 Oct;73(4):533-46 - PubMed
  6. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3036-43 - PubMed
  7. Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):257-62 - PubMed
  8. Development. 1992 Apr;114(4):869-76 - PubMed
  9. Am J Ophthalmol. 2012 May;153(5):840-849.e2 - PubMed
  10. J Glaucoma. 2010 Oct-Nov;19(8):540-5 - PubMed
  11. Endocrinology. 2001 Dec;142(12):5158-66 - PubMed
  12. Acta Paediatr Scand Suppl. 1989;349:77-80; discussion 81-3 - PubMed
  13. J Cataract Refract Surg. 2005 Jan;31(1):156-62 - PubMed
  14. J Refract Surg. 2007 Jan;23(1):66-75 - PubMed
  15. J Cataract Refract Surg. 2007 Sep;33(9):1499-501 - PubMed
  16. Ophthalmology. 2006 Jul;113(7):1197.e1-5 - PubMed
  17. Surv Ophthalmol. 2007 Nov;52 Suppl 2:S109-14 - PubMed
  18. Exp Eye Res. 1994 May;58(5):553-61 - PubMed
  19. Invest Ophthalmol Vis Sci. 2006 Feb;47(2):738-44 - PubMed
  20. Can J Physiol Pharmacol. 2003 Apr;81(4):371-84 - PubMed
  21. Surv Ophthalmol. 2000 Mar-Apr;44(5):367-408 - PubMed
  22. J Pediatr Endocrinol Metab. 1998 Mar-Apr;11(2):261-5 - PubMed
  23. J Endocrinol Invest. 2011 Feb;34(2):e30-5 - PubMed
  24. Development. 1989 Sep;107(1):123-30 - PubMed
  25. Acta Ophthalmol (Copenh). 1980 Dec;58(6):971-4 - PubMed
  26. Neurosci Lett. 2009 Aug 21;460(1):87-91 - PubMed
  27. Pediatr Endocrinol Rev. 2007 Sep;5(1):510-5 - PubMed
  28. Acta Ophthalmol Scand. 2005 Dec;83(6):751-3 - PubMed

Publication Types